Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review ...
Achieve Life Sciences announced that the U.S. Food and Drug Administration has awarded its investigational cytisinicline therapy a Commissioner's National Priority Voucher, enabling expedited review ...
Stocktwits on MSN
Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation
Shares of Achieve Life Sciences, Inc. (ACHV) soared 32% on Friday afternoon after the company said that the U.S. Food and Drug Administration (FDA) awarded the company a Commissioner's National ...
InvestorsHub on MSN
Achieve Life Sciences shares surge on FDA priority voucher news
Shares of Achieve Life Sciences (NASDAQ:ACHV) jumped 22.7% in premarket trading Friday after the company revealed it has been ...
FDA accepts Achieve Life Sciences' NDA for cytisinicline in smoking cessation. Promising vaping results boost market ...
The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...
The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...
WASHINGTON -- A loophole that vaping companies have used to circumvent regulators and keep their products on shelves closed this week, enabling the US Food and Drug Administration to go after myriad ...
The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and Sanofi to complete the approval process in one to two months.
U.S. Marshals and federal agents from the FDA raided a facility in Bensenville, Illinois, that distributes vaping products.
What is Tobacco Harm Reduction (THR)? #THRfacts campaign aims to educate the community about a science-based way to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results